Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Nasopharyngeal Carcinoma, EBV

Anthony Chan

MD

🏢Chinese University of Hong Kong🌐Hong Kong

Professor

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Anthony Chan at CUHK has contributed to nasopharyngeal carcinoma (NPC) research, including clinical trials establishing induction chemotherapy regimens and EBV plasma DNA as a biomarker for treatment response and surveillance. NPC is endemic in southern China and Southeast Asia, where EBV drives nearly all cases, and his research has contributed to improving treatment outcomes in this EBV-associated head and neck malignancy.

Share:

🧪Research Fields 研究领域

nasopharyngeal carcinoma EBV
NPC chemotherapy treatment
EBV-associated NPC biology
plasma EBV DNA NPC
induction chemotherapy NPC

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Anthony Chan 的研究动态

Follow Anthony Chan's research updates

留下邮箱,当我们发布与 Anthony Chan(Chinese University of Hong Kong)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment